Anti-apoptotic gene transcription signature of salivary gland neoplasms

BMC Cancer

Carolina Cavaliéri Gomes¹  Vanessa Fátima Bernardes³  Marina Gonçalves Diniz³  Luiz De Marco²  Ricardo Santiago Gomez³ 

[1] Department of Pathology, Universidade Federal de Minas Gerais, Belo Horizonte, Brazil

[2] Department of Surgery, Universidade Federal de Minas Gerais, Belo Horizonte, Brazil

[3] Department of Oral Surgery and Pathology, Universidade Federal de Minas Gerais, Belo Horizonte, Brazil

关键词: Tumour size;    Cell proliferation;    p53;    Transcription;    Caspase 3;    Bax;    Bcl-2;    Apoptosis;    Pleomorphic adenoma;    Salivary gland neoplasms;   

Others  :  1080546
DOI  :  10.1186/1471-2407-12-61

 received in 2011-09-12, accepted in 2012-02-07,  发布年份 2012

【 摘 要 】

Background

Development of accurate therapeutic approaches to salivary gland neoplasms depends on better understanding of their molecular pathogenesis. Tumour growth is regulated by the balance between proliferation and apoptosis. Few studies have investigated apoptosis in salivary tumours relying almost exclusively on immunohistochemistry or TUNEL assay. Furthermore, there is no information regarding the mRNA expression profile of apoptotic genes in salivary tumors. Our objective was to investigate the quantitative expression of BCL-2 (anti-apoptotic), BAX and Caspase3 (pro-apoptotic genes) mRNAs in salivary gland neoplasms and examine the association of these data with tumour size, proliferative activity and p53 staining (parameters associated with a poor prognosis of salivary tumours patients).

Methods

We investigated the apoptotic profile of salivary neoplasms in twenty fresh samples of benign and seven samples of malignant salivary neoplasms, using quantitative real time PCR. We further assessed p53 and ki-67 immunopositivity and obtained clinical tumour size data.

Results

We demonstrated that BCL-2 mRNA is overexpressed in salivary neoplasms, leading to an overall anti-apoptotic profile. We also found an association between the anti-apoptotic index (BCL-2/BAX) with p53 immunoexpression. A higher proliferative activity was found in the malignant tumours. In addition, tumour size was associated with cell proliferation but not with the transcription of apoptotic genes.

Conclusion

In conclusion, we show an anti-apoptotic gene expression profile in salivary neoplasms in association with p53 staining, but independent of cell proliferation and tumour size.

【 授权许可】

   
2012 Gomes et al; BioMed Central Ltd.

【 图 表 】

Figure 1.

Figure 2.

【 参考文献 】

• [1]Eveson JW, Auclair P, Gnepp DR, El-Naggar AK: Tumours of the salivary glands: introduction. In Pathology & Genetics Head and Neck Tumours. Edited by Barnes L, Eveson JW, Reichart P, Sidransky D. Lyon: IARC Press; 2005:212-215.
• [2]Ettl T, Schwarz S, Kleinsasser N, Hartmann A, Reichert TE, Driemel O: Overexpression of EGFR and absence of C-KIT expression correlate with poor prognosis in salivary gland carcinomas. Histopathology 2008, 53(5):567-577.
• [3]Chandana SR, Conley BA: Salivary gland cancers: current treatments, molecular characteristics and new therapies. Expert Rev Anticancer Ther 2008, 8(4):645-652.
• [4]Cotter TG: Apoptosis and cancer: the genesis of a research field. Nat Rev Cancer 2009, 9(7):501-507.
• [5]Tsujimoto Y, Finger LR, Yunis J, Nowell PC, Croce CM: Cloning of the chromosome breakpoint of neoplastic B cells with the t(14;18) chromosome translocation. Science 1984, 226(4678):1097-1099.
• [6]Sasi N, Hwang M, Jaboin J, Csiki I, Lu B: Regulated cell death pathways: new twists in modulation of BCL2 family function. Mol Cancer Ther 2009, 8(6):1421-1429.
• [7]Certo M, Del Gaizo Moore V, Nishino M, Wei G, Korsmeyer S, Armstrong SA, et al.: Mitochondria primed by death signals determine cellular addiction to antiapoptotic BCL-2 family members. Cancer Cell 2006, 9(5):351-365.
• [8]Antonsson B: Bax and other pro-apoptotic Bcl-2 family "killer-proteins" and their victim, the mitochondrion. Cell Tissue Res 2001, 306(3):347-361.
• [9]Creagh EM, Martin SJ: Caspases: cellular demolition experts. Biochem Soc Trans 2001, 29(pt6):696-702.
• [10]Nicholson DW, Ali A, Thornberry NA, Vaillancourt JP, Ding CK, Gallant M, et al.: Identification and inhibition of the ICE/CED-3 protease necessary for mammalian apoptosis. Nature 1995, 376(6535):37-43.
• [11]Soini Y, Törmänen U, Pääkkö P: Apoptosis is inversely related to bcl-2 but not to Bax expression in salivary gland tumours. Histopathology 1998, 32(1):28-34.
• [12]Fujita S, Shibata Y, Takahashi H, Tsuda N: Apoptosis-induced and -suppressed cells in salivary gland adenoid cystic carcinoma: correlation with histological growth patterns. Oral Dis 1999, 5(2):117-122.
• [13]Yin HF, Okada N, Takagi M: Apoptosis and apoptotic-related factors in mucoepidermoid carcinoma of the oral minor salivary glands. Pathol Int 2000, 50(8):603-609.
• [14]Aoki T, Tsukinoki K, Karakida K, Ota Y, Otsuru M, Kaneko A: Expression of cyclooxygenase-2, Bcl-2 and Ki-67 in pleomorphic adenoma with special reference to tumor proliferation and apoptosis. Oral Oncol 2004, 40(9):954-959.
• [15]Jia L, Esguerra RL, Tang X, Yin H, Sakamoto K, Okada N, et al.: Prognostic value of apoptosis and apoptosis-associated proteins in salivary gland adenoid cystic carcinoma. Pathol Int 2004, 54(4):217-223.
• [16]Ben-Izhak O, Laster Z, Araidy S, Nagler RM: TUNEL-an efficient prognosis predictor of salivary malignancies. Br J Cancer 2007, 96(7):1101-1106.
• [17]Ben-Izhak O, Laster Z, Akrish S, Muska E, Gan S, Nagler RM: The salivary tip of the p53 mutagenesis iceberg: novel insights. Cancer Biomark 2009, 5(1):23-31.
• [18]Marques YM, de Lima Mde D, de Melo Alves Sde M Jr, Soares FA, de Araújo VC, Pinto Ddos S Jr, Mantesso A: Mdm2, p53, p21 and pAKT protein pathways in benign neoplasms of the salivary gland. Oral Oncol 2008, 44(9):903-908.
• [19]Oltvai ZN, Milliman CL, Korsmeyer SJ: Bcl-2 heterodimerizes in vivo with a conserved homolog, Bax, that accelerates programmed cell death. Cell 1993, 74(4):609-619.
• [20]Miyashita T, Reed JC: Tumor suppressor p53 is a direct transcriptional activator of the human bax gene. Cell 1995, 80(2):293-299.
• [21]Vojtĕsek B, Bártek J, Midgley CA, Lane DP: An immunochemical analysis of the human nuclear phosphoprotein p53. New monoclonal antibodies and epitope mapping using recombinant p53. J Immunol Methods 1992, 151(1-2):237-244.